Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,030,635
+$941,628 QoQ
Shares Held
1,693
+43.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#2,486
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWARD FINANCIAL SERVICES, LTD. holds $8,323,786 across 9 Drug Manufacturers - General names. LLY ranks #1 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,693 | $2,030,635 | |
| 2 | JNJ |
Johnson & Johnson
|
7,616 | $1,934,235 | |
| 3 | ABBV |
AbbVie Inc.
|
5,209 | $1,310,792 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,945 | $1,149,432 | |
| 5 | AMGN |
Amgen Inc
|
2,105 | $762,262 | |
| 6 | AZN |
Astrazeneca PLC
|
2,120 | $401,994 | |
| 7 | PFE |
Pfizer Inc
|
12,628 | $304,082 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,908 | $225,178 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,030,635 | 1,693 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,089,007 | 1,184 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $983,332 | 915 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $499,765 | 655 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $461,481 | 592 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $578,962 | 701 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $487,904 | 632 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $380,954 | 430 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $400,177 | 442 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $315,073 | 405 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $238,997 | 410 | Shares | Sole | 2024-01-09 | |
| No filing history on record for this holder in this stock. | ||||||